Lis Ewa T, O'Neill Bryan M, Gil-Lamaignere Cristina, Chin Jodie K, Romesberg Floyd E
Department of Chemistry, The Scripps Research Institute, CB262R, 10550N. Torrey Pines Road, La Jolla, CA 92037, United States.
DNA Repair (Amst). 2008 May 3;7(5):801-10. doi: 10.1016/j.dnarep.2008.02.007. Epub 2008 Apr 8.
Mutation in response to most types of DNA damage is thought to be mediated by the error-prone sub-branch of post-replication repair and the associated translesion synthesis polymerases. To further understand the mutagenic response to DNA damage, we screened a collection of 4848 haploid gene deletion strains of Saccharomyces cerevisiae for decreased damage-induced mutation of the CAN1 gene. Through extensive quantitative validation of the strains identified by the screen, we identified ten genes, which included error-prone post-replication repair genes known to be involved in induced mutation, as well as two additional genes, FYV6 and RNR4. We demonstrate that FYV6 and RNR4 are epistatic with respect to induced mutation, and that they function, at least partially, independently of post-replication repair. This pathway of induced mutation appears to be mediated by an increase in dNTP levels that facilitates lesion bypass by the replicative polymerase Pol delta, and it is as important as error-prone post-replication repair in the case of UV- and MMS-induced mutation, but solely responsible for EMS-induced mutation. We show that Rnr4/Pol delta-induced mutation is efficiently inhibited by hydroxyurea, a small molecule inhibitor of ribonucleotide reductase, suggesting that if similar pathways exist in human cells, intervention in some forms of mutation may be possible.
大多数类型的DNA损伤所引发的突变被认为是由复制后修复的易错分支以及相关的跨损伤合成聚合酶介导的。为了进一步了解对DNA损伤的诱变反应,我们对4848个酿酒酵母单倍体基因缺失菌株进行了筛选,以寻找CAN1基因损伤诱导突变减少的菌株。通过对筛选出的菌株进行广泛的定量验证,我们鉴定出了十个基因,其中包括已知参与诱导突变的易错复制后修复基因,以及另外两个基因FYV6和RNR4。我们证明,FYV6和RNR4在诱导突变方面是上位性的,并且它们至少部分独立于复制后修复发挥作用。这种诱导突变途径似乎是由dNTP水平的增加介导的,dNTP水平的增加促进了复制性聚合酶Pol δ绕过损伤,并且在紫外线和甲基磺酸甲酯诱导的突变情况下,它与易错复制后修复同样重要,但仅负责甲基磺酸乙酯诱导的突变。我们表明,核糖核苷酸还原酶的小分子抑制剂羟基脲能有效抑制Rnr4/Pol δ诱导的突变,这表明如果人类细胞中存在类似途径,那么对某些形式的突变进行干预可能是可行的。